Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

The approval of the first oncolytic virus for the treatment of metastatic melanoma and the compiling evidence that the use of oncolytic viruses can enhance cancer immunotherapies targeted against various immune checkpoint proteins has attracted great interest in the field of cancer virotherapy. We h...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Erkko Ylösmäki, Cristina Malorzo, Cristian Capasso, Oona Honkasalo, Manlio Fusciello, Beatriz Martins, Leena Ylösmäki, Antti Louna, Sara Feola, Henrik Paavilainen, Karita Peltonen, Veijo Hukkanen, Tapani Viitala, Vincenzo Cerullo
Natura: Artigo
Lingua:inglese
Pubblicazione: 2018
Accesso online:https://doi.org/10.1016/j.ymthe.2018.06.008
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!